Bill Status of SB2994

  1. Home
  2. Legislation
  3. Bill Status

SB2994 - 104th General Assembly

GENETIC PRIVACY-NEUROTECH
Last Action
2/18/2026 - Senate: To AI and Social Media
Senate Sponsors
Sen. Rachel Ventura
Statutes Amended In Order of Appearance
410 ILCS 513/5
410 ILCS 513/10
410 ILCS 513/20
410 ILCS 513/25
410 ILCS 513/27 new
410 ILCS 513/40
410 ILCS 513/50
Synopsis As Introduced
Amends the Genetic Information Privacy Act. Adds legislative findings. Defines "neurotechnology" and "neurotechnology data". Prohibits insurers from using genetic testing or neurotechnology data (rather than only genetic testing) for nontherapeutic purposes or underwriting, with limited exceptions. Prohibits employers, employment agencies, labor organizations, and licensing agencies from requesting, requiring, or using neurotechnology data in employment decisions, subject to specified exceptions. Adds new provisions governing confidentiality, consent, privacy policies, and security requirements for entities collecting neurotechnology data. Regulates disclosure to government agencies and sets conditions for clinical research. Makes conforming changes. Effective January 1, 2027.
Actions
Date Chamber Action
1/29/2026 Senate Filed with Secretary by Sen. Rachel Ventura
1/29/2026 Senate First Reading
1/29/2026 Senate Referred to Assignments
2/10/2026 Senate Assigned to Executive
2/18/2026 Senate To AI and Social Media
3/05/2026 Senate Senate Committee Amendment No. 1 Filed with Secretary by Sen. Rachel Ventura
3/05/2026 Senate Senate Committee Amendment No. 1 Referred to Assignments
3/10/2026 Senate Senate Committee Amendment No. 1 Assignments Refers to Executive
3/11/2026 Senate Senate Committee Amendment No. 1 To AI and Social Media
3/13/2026 Senate Rule 2-10 Committee Deadline Established As March 27, 2026
3/27/2026 Senate Rule 2-10 Committee Deadline Established As April 24, 2026